Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the efficacy and safety of the investigational drug Volixibat for pruritus in patients with Primary Biliary Cholangitis and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Volixibat (volixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Primary Biliary Cholangitis, PBC | Phase 2 | Status: RECRUITING